Evidence map›Paper›PMID 41835272›Full record

ArticleFrontiers in plant science2026

Construction and application of multiple nucleotide polymorphism-based DNA fingerprinting for

Min Tang, Yuqing Long, Juan Zeng, Wei Xiang, Peng Huang, Gang Wang, Jianguo Zeng

Abstract read
In one paragraph

Article in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Min Tang *Department of Pharmacy, Yiyang Medical College, Yiyang, China.
Yuqing Long *Department of Pharmacy, Yiyang Medical College, Yiyang, China.
Juan ZengDepartment of Pharmacy, Yiyang Medical College, Yiyang, China.
Wei XiangChinese Medicinal Materials Breeding Innovation Center, Yuelushan Laboratory, Changsha, China.
Peng HuangChinese Medicinal Materials Breeding Innovation Center, Yuelushan Laboratory, Changsha, China.
Gang WangWuhan Mingliao Biotechnology Co., Ltd., Wuhan, China.
Jianguo ZengChinese Medicinal Materials Breeding Innovation Center, Yuelushan Laboratory, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: We successfully developed a high-throughput identification system based on multiple nucleotide polymorphism (MNP) markers for Results: Validation results revealed that this marker panel had excellent amplification efficiency and polymorphism across all 80 tested accessions. For the MNP markers, the average number of allelic genotypes reached 28.95 ± 15.11. The polymorphism information content was 0.73 ± 0.16. Both metrics were substantially superior to those of traditional identification methods. Both phylogenetic analysis and principal component analysis distinguished all the tested accessions, with an identification accuracy rate of 99.90%. A unique molecular ID code was assigned to each cultivar. Discussion: The MNP marker system developed in this study combines the advantages of high throughput, high accuracy, and favorable reproducibility. It provides the technical means and solutions for the authenticity identification of

Indexed as

construction and application of technologyDNA fingerprintinggenetic markermultiple nucleotide polymorphism (MNP)polygonatum cyrtonemaspecies identification

Identifiers

PMID41835272
PMCPMC12982458

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.